Dr. Federico P. Girardi specializes in the surgical treatment of different spinal disorders, including but not limited to: degenerative (disc herniation, degenerative disc disease, stenosis), deformity (scoliosis, kyphosis, flat-back), metabolic (osteoporosis), fractures, and tumors of the cervical, thoracic and lumbar spine.
He has done extensive clinical research involving the areas of minimally invasive surgery, clinical outcomes of different surgical procedures, and imaging modalities of the spine. Dr. Girardi is currently involved in the STRIVE study, a worldwide clinical trial to see if an investigational vaccine given before spinal surgery can prevent infection. He is also interested in the basic science aspects of bone, disc and nerve tissue regeneration as well as the investigation of alternatives to spinal fusion for the treatment of degenerative disc disease.
Attending Orthopaedic Surgeon, Hospital for Special Surgery
Professor of Orthopaedic Surgery, Weill Cornell Medical College
Associate Scientist, Research Division, Hospital for Special Surgery
Lumbar, Thoracic, and Cervical Spinal Disorders
Degenerative Conditions: Disc herniations, Degenerative Disc Disease, Spinal Stenosis, Spondylolisthesis
Spinal Deformities (Scoliosis, Kyphosis)
Minimally Invasive Surgery
Spine Non-fusion Surgery
Castle Connolly America's Top Doctors, 2018
Castle Connolly Top Doctors in New York Metro Area, 2015-2018
New York Magazine Top Doctors, 2018
Team Science Award, Translational Science (ACRT, AFMR, APOR, SCTS) Washington, DC, 2012
Best Resident Research Study, 1993
Member, American Medical Association
Member, Hospital for Special Surgery Alumni Association
Member, Medical Society of the State of New York
Member, New York County Medical Society
Member, Scoliosis Association
Member, Argentine Association of Orthopaedics and Traumatology (AAOT)
Member Nucleus Arthroplasty Society (SONA)
Member, Society for the Lateral Access Surgery (SOLAS)
Member, North American Spine Society (NASS)
Member, Scoliosis Research Society (SRS)
Member, European Spine Society (ESS)
Member, International Society for the Study of the Lumbar Spine (ISSLS)
Member, Spine Arthroplasty Society (SAS)
Blue Cross Blue Shield PPO HMO POS
Blue Cross Blue Shield Pathway
Blue Cross Blue Shield Pathway Enhanced
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.
Dr. Girardi accepts the following insurance plans. Please check to see if your insurance is on this list before proceeding.
Please note, if your insurance is not on this list, you may still have coverage subject to the availability of out-of-network benefits.
If you do not wish to go out-of-network, our Physician Referral Service will help you find an appropriate doctor.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Girardi as of April 14, 2017.
Centinel Spine – Scientific Advisory Board; Ownership interest
DePuy Spine, LLC – Inventor; Royalties for development of Lateral Access and Implant System
EIT Emerging Implant Technologies - Consultant; Advisory Board
Ethicon - Consultant
Healthpoint Capital Partners, LP – Scientific Advisory Board; Investment interest
LANX, Inc. - Consultant; Designer; Royalties for the Next Generation Spinous Process Fixation System
Liventa Bioscience – Investment interest
MiMedx Group, Inc. – Research support
NuVasive, Inc. – Consultant; Designer; Royalties for the development of Osteoporotic Fixation Implants
Ortho Development Corp. - Designer; Royalties for design and consultation services for Pagoda Spine System
Paradigm Spine, LLC - Scientific Advisory Board; Ownership interests
Spinal Kinetics, Inc. - Scientific Advisory Board; Stock options
Spineart USA - Scientific Advisory Board; Consultant
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
MD, Universidad Nacional de Rosario, Rosario, Argentina
Hospital de Clinicas “Jose de San Martin” Buenos Aires University, Orthopedic Surgery and Traumatology, Buenos Aires, Argentina
Hospital for Special Surgery, Spine & Scoliosis Surgery, New York
American Board of Orthopaedic Surgery
New York, Connecticut
2000, Present, Editorial Reviewer, SPINE Journal, Editor-in-Chief Dr. James N. Weinstein
2001, Editorial Reviewer, Journal of Orthopaedic Research, Editor-in-Chief Timothy M. Wright, PhD
2002, Guest Editor, The Orthopedic Clinics of North America, Advances in Spine Surgery
2003, Editorial Reviewer, Journal Clinical Drug Investigation
2004, Editorial Reviewer, Clinical Orthopedics and Related Research
2005, Editorial Reviewer, British Medical Journal
2004, Editorial Reviewer, European Spine Journal
2007, Deputy Editor, Spine Arthroplasty Society Journal
2008 - Present, Contributing Author, Interactive Educational Program (IEP)
2009 - Present, Editorial Review Board Minimally Invasive Surgery
2010 - 2014, Editorial Board, World Journal of Orthopaedics
2011, Review Panel, Interactive Educational Program (IEP) Awards
2012, Deputy Editor, International Journal of Spine Surgery
Lebl DR, Sama AA, Pumberger M, Kotwal S, Cammisa FP Jr, Girardi FP: “Reamed Transacral Interbody Fusion for L5-S1 Pseudarthrosis: A Novel Salvage Technique in 10 Patients” J Spinal Disord Tech. 2012 Jan 17.
Kepler CK, Sharma AK, Huang RC, Meredith DS, Girardi FP, Cammisa FP Jr, Sama AA: ”Indirect Foraminal Decompression after Lateral Transpsoas Interbody Fusion” Journal of Neurosurgery: Spine 2012 Jan 27.
Taher F, Essig D, Lebl DR, Hughes AP, Sama AA, Cammisa FP, Girardi FP: “Lumbar Degenerative Disc Disease – Current and Future Concepts of Diagnosis and Management" Advances in Orthopedics 2012;2012:970752. Epub 2012 Apr 2.
Kepler CK, Huang RC, Sharma AK, Meredith DS, Metitiri O, Sama AA, Girardi FP, Cammisa FP: “Factors Influencing Segmental Lumbar Lordosis After Lateral Transpsoas Interbody Fusion” Orthop Surg. 2012 May;4(2):71-5.
Pawar A, Essig D, Girardi FP, Cammisa FP Jr, Fantini G, Hughes AP. Lateral Lumbar Interbody Fusion. Journal of the American Academy of Orthopaedic Surgery. In Press.
For more publications, please see the PubMed listing.
Current Research Includes:
Disc Replacement (Disc Prosthesis) and non-fusion technologies
Imaging of the spine
Minimally Invasive Surgery
Image Guided Stereotactic Surgery
HSS, along with medical centers around the country, in Europe, Japan, and Canada, is taking part in a study to evaluate the safety and efficacy of an investigational vaccine when administered to adults undergoing a spinal fusion surgical procedure. The research is part of the HSS commitment to quality by continually striving to improve long-term outcomes.
The goal of the study is to investigate whether a single vaccination given 10-60 days before spinal surgery can prevent Staphylococcus aureus (staph) infections. Although rare, affecting only 1 to 3% of patients nationwide, an infection is always serious and any measure that could potentially prevent an infection could improve patient outcomes.
The safety and tolerability of the current investigational vaccine for Staphylococcus aureus have already been studied in healthy adult participants in four previous clinical trials.
The next step is to study the safety and efficacy of this investigational vaccine in patients planning a spinal fusion surgical procedure.
The study is open to adults 18 to 85 years of age meeting certain criteria. Please consult your physician for more information.
Spine Care Institute at Hospital for Special Surgery